RBC Europe’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-295
| Closed | -$13.7K | – | 1213 |
|
|
2020
Q4 | $13.7K | Hold |
295
| – | – | ﹤0.01% | 818 |
|
|
2020
Q3 | $9.71K | Hold |
295
| – | – | ﹤0.01% | 805 |
|
|
2020
Q2 | $8.1K | Sell |
295
-7,155
| -96% | -$196K | ﹤0.01% | 804 |
|
|
2020
Q1 | $223K | Sell |
7,450
-5,370
| -42% | -$161K | 0.02% | 196 |
|
|
2019
Q4 | $355K | Buy |
12,820
+7,665
| +149% | +$212K | 0.03% | 190 |
|
|
2019
Q3 | $93.8K | Sell |
5,155
-2,120
| -29% | -$38.6K | 0.01% | 345 |
|
|
2019
Q2 | $178K | Buy |
7,275
+2,120
| +41% | +$52K | 0.02% | 260 |
|
|
2019
Q1 | $49K | Hold |
5,155
| – | – | 0.01% | 460 |
|
|
2018
Q4 | $45.6K | Hold |
5,155
| – | – | 0.01% | 458 |
|
|
2018
Q3 | $58K | Hold |
5,155
| – | – | 0.01% | 448 |
|
|
2018
Q2 | $66K | Buy |
+5,155
| New | +$66K | 0.01% | 415 |
|